Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of PEN 520.93 billion. The enterprise value is 679.09 billion.
| Market Cap | 520.93B |
| Enterprise Value | 679.09B |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Jan 23, 2026 |
Share Statistics
| Current Share Class | 5.69B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 5.68B |
Valuation Ratios
The trailing PE ratio is 19.93 and the forward PE ratio is 9.20.
| PE Ratio | 19.93 |
| Forward PE | 9.20 |
| PS Ratio | 2.47 |
| PB Ratio | 1.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 25.98 |
| EV / Sales | 3.24 |
| EV / EBITDA | 7.90 |
| EV / EBIT | 10.59 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | n/a |
| Interest Coverage | 7.17 |
Financial Efficiency
Return on equity (ROE) is 8.58% and return on invested capital (ROIC) is 13.68%.
| Return on Equity (ROE) | 8.58% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.68% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.60M |
| Profits Per Employee | 322,756 |
| Employee Count | 81,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -894.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.76% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +3.76% |
| 50-Day Moving Average | 25.82 |
| 200-Day Moving Average | 24.91 |
| Relative Strength Index (RSI) | 85.97 |
| Average Volume (20 Days) | 325 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.90 |
Income Statement
In the last 12 months, Pfizer had revenue of PEN 210.53 billion and earned 26.14 billion in profits. Earnings per share was 4.59.
| Revenue | 210.53B |
| Gross Profit | 159.59B |
| Operating Income | 64.47B |
| Pretax Income | 25.30B |
| Net Income | 26.14B |
| EBITDA | 86.42B |
| EBIT | 64.47B |
| Earnings Per Share (EPS) | 4.59 |
Balance Sheet
The company has 50.42 billion in cash and 208.37 billion in debt, with a net cash position of -157.96 billion.
| Cash & Cash Equivalents | 50.42B |
| Total Debt | 208.37B |
| Net Cash | -157.96B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 313.19B |
| Book Value Per Share | 54.91 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.
| Gross Margin | 75.81% |
| Operating Margin | 30.62% |
| Pretax Margin | 12.02% |
| Profit Margin | 12.42% |
| EBITDA Margin | 41.05% |
| EBIT Margin | 30.62% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.98, which amounts to a dividend yield of 21.68%.
| Dividend Per Share | 5.98 |
| Dividend Yield | 21.68% |
| Dividend Growth (YoY) | -4.96% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 130.38% |
| Buyback Yield | -0.23% |
| Shareholder Yield | 21.46% |
| Earnings Yield | 5.02% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |